TLIS
Talis Biomedical Corp
Price:  
4.38 
USD
Volume:  
51,017.00
United States | Health Care Equipment & Supplies
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TLIS WACC - Weighted Average Cost of Capital

The WACC of Talis Biomedical Corp (TLIS) is 5.5%.

The Cost of Equity of Talis Biomedical Corp (TLIS) is 7.40%.
The Cost of Debt of Talis Biomedical Corp (TLIS) is 5.00%.

Range Selected
Cost of equity 5.90% - 8.90% 7.40%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 4.8% - 6.3% 5.5%
WACC

TLIS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.45 0.72
Additional risk adjustments 0.0% 0.5%
Cost of equity 5.90% 8.90%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 4.8% 6.3%
Selected WACC 5.5%